VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-00994
Package ID: USCOURTS-cofc-1_22-vv-00994
Petitioner: Matthew Valentine
Filed: 2022-08-18
Decided: 2025-11-20
Vaccine: influenza
Vaccination date: 2019-09-11
Condition: acute transverse myelitis and acute disseminated encephalomyelitis
Outcome: compensated
Award amount USD: 150000

AI-assisted case summary:
On August 18, 2022, Matthew Valentine filed a petition alleging that an influenza vaccination administered on September 11, 2019 caused acute transverse myelitis and acute disseminated encephalomyelitis. He was 37 years old at vaccination.

Respondent denied that Mr. Valentine's alleged TM, ADEM, or residual effects were vaccine-caused. The public stipulation does not describe onset, diagnostic testing, hospitalization, treatment, expert opinions, or the biological mechanism alleged. On November 20, 2025, Chief Special Master Corcoran adopted the parties' stipulation and awarded $150,000.00 as a lump sum through counsel for all damages available under the Vaccine Act.

Theory of causation field:
Adult petitioner, age 37; influenza vaccine September 11, 2019; alleged acute transverse myelitis and ADEM. COMPENSATED by stipulation. Respondent denied causation; public text lacks clinical chronology, diagnostics, treatment, mechanism, or experts. Decision November 20, 2025. Award $150,000.00 lump sum. Petition filed August 18, 2022.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_22-vv-00994-0
Date issued/filed: 2026-01-07
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 11/20/2025) regarding 44 DECISION of Special Master - Stipulation. Signed by Special Master Jennifer A. Shah. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 22-994V
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
MATTHEW VALENTINE,
*
*
Petitioner, * UNPUBLISHED
*
*
v.
*
*
SECRETARY OF HEALTH AND * Filed: November 20, 2025
HUMAN SERVICES, *
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
Kenneth W. Thayer, III, Brandon J. Broderick, Attorney at Law, LLC, Ewing, NJ, for Petitioner.
Camille Jordan Webster, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION ON JOINT STIPULATION1
On August 18, 2022, Matthew Valentine (“Petitioner”) filed a petition seeking
compensation under the National Vaccine Injury Compensation Program (“the Vaccine
Program”).2 ECF No. 1 (“Pet.”). Petitioner alleges he suffered from acute transverse myelitis
(“TM”) and acute disseminated encephalomyelitis (“ADEM”) caused by the influenza (“flu”)
vaccination he received on September 11, 2019. See Stipulation ¶¶ 2, 4, dated November 20, 2025
(ECF No. 43); see also Pet.
Respondent denies “that [P]etitioner’s alleged TM and ADEM or its residual effects were
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet. As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 2 of 7
caused-in-fact by the flu vaccine; and denies that the flu vaccine caused [P]etitioner any other
injury or [P]etitioner’s current condition.” See Stipulation ¶ 6. Nonetheless, both parties, while
maintaining their above-stated positions, agreed in a stipulation filed November 20, 2025, that the
issues before them can be settled and that a decision should be entered awarding Petitioner
compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
a lump sum of $150,000.00 be paid through an ACH deposit to petitioner’s counsel’s
IOLTA account for prompt disbursement to petitioner.
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a). Id.
I approve a Vaccine Program award in the requested amount set forth above to be made to
Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk
of the Court is directed to enter judgment herewith.3
IT IS SO ORDERED.
s/ Jennifer A. Shah
Jennifer A. Shah
Special Master
3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.
2

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 3 of 7

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 4 of 7

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 5 of 7

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 6 of 7

Case 1:22-vv-00994-UNJ Document 46 Filed 01/07/26 Page 7 of 7